Andrew Kleinberg

Title: Andrew Kleinberg: Innovator in Mass Spectrometry

Introduction

Andrew Kleinberg is a notable inventor based in Roslyn Heights, NY (US). He has made significant contributions to the field of mass spectrometry, particularly in the quantification of post-translational modifications of proteins. With a total of 3 patents, his work has advanced the methodologies used in protein analysis.

Latest Patents

Kleinberg's latest patents focus on the "Tandem mass tag multiplexed quantitation of post-translational modifications of proteins." These patents disclose methods for quantifying multiple quality attributes of various samples in a single mass spectrometry (MS) run. The process involves digesting samples with a Tris-free buffer solution, labeling peptides with specific Tandem Mass Tag (TMT) reagents, and analyzing the combined sample solution through targeted mass spectral analysis. This innovative approach allows for the efficient quantification of multiple quality attributes in a streamlined manner.

Career Highlights

Andrew Kleinberg is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to apply his expertise in mass spectrometry. His work at Regeneron has positioned him as a key player in the development of advanced analytical techniques in the pharmaceutical industry.

Collaborations

Kleinberg collaborates with Yuan Mao, contributing to the innovative research environment at Regeneron Pharmaceuticals. Their combined efforts enhance the capabilities of the research team in tackling complex scientific challenges.

Conclusion

Andrew Kleinberg's contributions to mass spectrometry and protein analysis exemplify the impact of innovation in scientific research. His patents and work at Regeneron Pharmaceuticals highlight the importance of advancing methodologies in the field.